Awarded Grants

The ODC offers over 50 grant opportunities in 30+ disease areas annually to researchers across the globe, as well as within the Penn and CHOP communities. Since 2011, our grant programs have funded $17.2 million in rare disease research.

See below for a complete list of ODC-awarded grants since 2011. 

Full list of 2018 MDBR Awardees

Awarded Grants

Displaying Results 131 - 140 of 168

Awardee Project Title Institution Grant Amount Funding Year
Martin Rosewich Role of microRNAs in the pathophysiology of bronchiolitis obliterans Goethe-University - Children's Hospital MDBR - Bronchiolitis Obliterans $50,500 2015
Charles Schwartz, PhD Role of mitochndria and ROS in etiology of SRS Greenwood Genetic Center MDBR - Snyder-Robinson $53,000 2016
Vera Krymskaya, PhD, MBA STAT3 in Pulmonary Lymphangioleiomyomatosis (LAM) University of Pennsylvania MDBR - LAM $60,000 2014
Robert Casero, PhD Self-immolating NanoSpermine (nSpm) as a novel treatment approach to restore normal spermine/spermidine ratios in Snyder-Robinson Syndrome (SRS) models John Hopkins University School of Medicine MDBR - Snyder-Robinson Syndrome $42,866 2018
Charles Nelson, PhD / Michela Fagiolini, PhD / Heather Olson, MD Sensory evoked potentials as a biomarker in CDKL5 Boston Children’s Hospital / Harvard Medical School MDBR - CDKL5 $53,500 2016
Michael James, Dphil Structure-guided development of small molecule “pharmacological chaperones” for the treatment of Mucopolysaccharidosis I University of Alberta MPS I $300,000 2014
Jianrong Tang, PhD Studies of forniceal deep brain stimulation and hippocampal memory in CDKL5 mice Baylor College of Medicine CDKL5 $150,000 2016
Garry Cutting, MD Systematic Evaluation of a Cluster of Nonsense Mutations in Exon 22 of CFTR to Inform Treatment Johns Hopkins University School of Medicine MDBR - Cystic Fibrosis $69,000 2015
David Kwiatkowski, MD, PhD TSC2 mutation analysis as a biomarker for lymphangioleiomyomatosis (LAM) Brigham and Women's Hospital MDBR - LAM $50,500 2015
Charles Vite, BS, DVM, PhD Targeted AAV gene therapy for vertical supranuclear gaze palsy and dysphagia University of Pennsylvania MDBR - NPC $53,500 2015